摘要
目的对糖尿病合并甲亢辅助治疗中使用美托洛尔的疗效进行分析和研究。方法选择该院2012年7月—2016年6月收治的50例糖尿病合并甲亢患者作为研究对象,随机将其划分为对照组和观察组,每组25例。采用常规治疗方式治疗对照组,在此基础上,采用美托洛尔辅助治疗观察组,对两组患者的治疗效果进行分析和比较。结果两组患者治疗前的空腹血糖浓度和餐后2 h血糖浓度均差异无统计学意义(P>0.05),观察组治疗后的空腹血糖浓度和餐后2 h血糖浓度均明显低于对照组,差异有统计学意义(P<0.05)。观察组总有效率明显高于对照组,差异有统计学意义(P<0.05)。结论糖尿病合并甲亢辅助治疗中使用美托洛尔具有很好的效果,能够极大地改善患者的临床症状。
Objective To analyze and study the efficacy of metoprolol in the treatment of diabetes complicated with hyperthyroidism. Methods Fifty patients from July 2012 to Jun 2016 with diabetes mellitus complicated with hyperthyroidism admitted to our hospital were randomly divided into control group and observation group, with 25 cases in each group. The control group was treated with conventional treatment. On the basis of this, the metoprolol-assisted treatment observation group was used to analyze and compare the therapeutic effects of the two groups. Results There was no statistically significant difference between the fasting blood glucose concentration and the postprandial 2 h blood glucose concentration in the two groups (P>0.05). The fasting blood glucose concentration and the postprandial 2 h blood glucose concentration in the observation group were significantly lower than those in the control group. The difference was statistically significant (P<0.05). The total effective rate of the observation group was significantly higher than that of the control group, which was statistically significant (P<0.05). Conclusion The use of metoprolol in the treatment of diabetes with hyperthyroidism has a very good effect and can greatly improve the clinical symptoms of patients.
作者
程培
CHENG Pei(Department of Endocrinology, Affiliated Hospital of Heze Medical College, Heze, Shandong Province, 274000 China)
出处
《糖尿病新世界》
2019年第16期70-71,共2页
Diabetes New World Magazine
关键词
糖尿病
甲亢
美托洛尔
Diabetes
Hyperthyroidism
Metoprolol